STEREOTAXIS INC (STXS)

0.58
OTC Markets
Prev Close 0.58
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.51 / 1.10
Exchange OTC Markets
Shares Outstanding 24.00M
Market Cap 34.73M
Div & Yield N.A. (N.A)

Latest News

Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results

Stereotaxis Announces $10.0 Million Non-Dilutive Financing From Early Warrant Exercise
Stereotaxis To Report Fourth Quarter And Full Year 2017 Financial Results On March 6, 2018

Stereotaxis To Report Fourth Quarter And Full Year 2017 Financial Results On March 6, 2018

European Heart Rhythm Association Highlights Occupational Risk Of Radiation Exposure In Electrophysiology Procedures

European Heart Rhythm Association Highlights Occupational Risk Of Radiation Exposure In Electrophysiology Procedures

Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results

Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results

Stereotaxis Receives Regulatory Approval Of E-Contact™ Module In Canada

Stereotaxis Receives Regulatory Approval Of E-Contact™ Module In Canada

First Procedures Performed at Toronto's Sunnybrook Health Sciences Centre

Stereotaxis To Present At 29th Annual Piper Jaffray Healthcare Conference

Stereotaxis To Present At 29th Annual Piper Jaffray Healthcare Conference

Stereotaxis Reports Third Quarter 2017 Financial Results

Stereotaxis Reports Third Quarter 2017 Financial Results

Stereotaxis To Report Third Quarter 2017 Financial Results On November 9, 2017

Stereotaxis To Report Third Quarter 2017 Financial Results On November 9, 2017

Stereotaxis To Attend Asia Pacific Heart Rhythm Society Conference And Announces Japan Procedure Milestone

Stereotaxis To Attend Asia Pacific Heart Rhythm Society Conference And Announces Japan Procedure Milestone

Continues to Grow Utilization and Enthusiasm for Robotic Technologies in Asia Pacific Market

One Hundred Thousand Procedure Milestone Achieved By Stereotaxis' Robotic Technology

One Hundred Thousand Procedure Milestone Achieved By Stereotaxis' Robotic Technology

Research Finds That Stereotaxis Robotic Technology Provides Significant Advantages In Treatment Of Ventricular Tachycardia Compared To Manual Techniques

Research Finds That Stereotaxis Robotic Technology Provides Significant Advantages In Treatment Of Ventricular Tachycardia Compared To Manual Techniques

Stereotaxis Reports Second Quarter 2017 Financial Results

Stereotaxis Reports Second Quarter 2017 Financial Results

Stereotaxis To Report Second Quarter 2017 Financial Results On August 10, 2017

Stereotaxis To Report Second Quarter 2017 Financial Results On August 10, 2017

Princess Grace Hospital Publishes Data Demonstrating More Rapid Transmural Lesion Formation Utilizing Stereotaxis Robotic Technology

Princess Grace Hospital Publishes Data Demonstrating More Rapid Transmural Lesion Formation Utilizing Stereotaxis Robotic Technology

Stereotaxis Receives Second Odyssey Vision™ System Orders From Two Leading Heart Hospitals

Stereotaxis Receives Second Odyssey Vision™ System Orders From Two Leading Heart Hospitals

Stereotaxis Launches The E-Contact™ Module In Europe

New Technology will be Showcased at EHRA EUROPACE-CARDIOSTIM 2017

Stereotaxis Reports 2017 First Quarter Financial Results

Stereotaxis To Report First Quarter 2017 Financial Results On May 8, 2017

Stereotaxis' Leadership In Robotic Cardiac Ablation To Be Showcased At Heart Rhythm 2017 And First Annual Meeting Of Society For Cardiac Robotic Navigation (Americas)

Clinical Study Validates Efficiencies Of Stereotaxis Niobe® ES System Compared To Niobe II System

Stereotaxis To Present At 29th Annual ROTH Conference

First Site In Japan To Install Stereotaxis Technology Completes 250 Procedures

Takatsuki Hospital Achieves Significant Levels of Success and Safety for Ablation Patients

Montreal Heart Institute Implements Stereotaxis Technologies

Internationally Recognized Cardiology Center Utilizing Niobe® ES System for Cardiac Ablation

Stereotaxis Announces Management Transition And 2016 Financial Results

Stereotaxis Launches Interface Between Niobe® ES System And Philips' State-of-the-art X-ray System

Stereotaxis Launches Interface Between Niobe® ES System And Philips' State-of-the-art X-ray System

Stereotaxis Reports 2016 Third Quarter Financial Results

Stereotaxis Reports 2016 Third Quarter Financial Results

Stereotaxis To Report Third Quarter 2016 Financial Results On November 7, 2016

Stereotaxis To Report Third Quarter 2016 Financial Results On November 7, 2016

Robert Wood Johnson University Hospital Physician Surpasses 500 Procedures Using Stereotaxis Niobe® System

Robert Wood Johnson University Hospital Physician Surpasses 500 Procedures Using Stereotaxis Niobe® System

Stereotaxis Technologies To Be Highlighted At Society For Cardiac Robotic Navigation's Inaugural Meeting In Amsterdam

Stereotaxis Technologies To Be Highlighted At Society For Cardiac Robotic Navigation's Inaugural Meeting In Amsterdam

Load More

From Our Partners

J&J cost cutting plan may pressure suppliers - Bloomberg
SeekingAlpha

Stereotaxis Is Back To Stay
SeekingAlpha

Stereotaxis reports Q4 results
SeekingAlpha

Stereotaxis, Inc. 2017 Q3 - Results - Earnings Call Slides
SeekingAlpha

Stereotaxis reports Q3 results
SeekingAlpha

Corindus: You Might Want To Sit Down For This
SeekingAlpha

Stereotaxis reports Q2 results
SeekingAlpha

Stereotaxis reports Q1 results
SeekingAlpha

Electrophysiology Devices: Key Players In A Fast-Growing Market
SeekingAlpha

Stereotaxis reports preliminary Q4 results
SeekingAlpha

Stereotaxis reports Q3 results
SeekingAlpha

Stereotaxis commercial chief bids adieu
SeekingAlpha

Stereotaxis nabs $24M in equity financing; shares up 25%
SeekingAlpha

Stereotaxis reports Q2 results
SeekingAlpha

Morning Market Movers
Benzinga

Watchlist

Trending
A Flash Flood of Selling: Cramer's 'Mad Money' Recap (Thursday 4/19/18)
15 Collectibles That Are Completely Worthless (Such as Your McDonald's Toys)
Will Tesla Stock Tumble 33% to $195?